The Psychiatry Consortium is a strategic collaboration of leading medical research charities and pharmaceutical companies focusing on the challenge of identifying and validating novel drug targets to address the unmet therapeutic needs of people living with mental health conditions. The Consortium is managed by the Medicines Discovery Catapult and supported by Wellcome...
The Psychiatry Consortium provides opportunities for funding, collaboration and knowledge exchange - to drive innovation in psychiatric drug discovery.